Prognostic molecular markers in hepatocellular carcinoma (Review article

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide, representing also the main cause of death among cirrhotic patients. In contrast to most other solid tumors, the underlying cirrhotic liver disease in HCC patients greatly impairs tumor related prognosis, conferring this neoplasm a unique situation, in which accurate prognostic prediction is a relevant and unmet need. Al...

Prognostic and Predictive Clinical, Pathological and Molecular Markers for Oral Squamous Cell Carcinoma: review of articles

Approximately 90% of all head and neck malignancies and 94% of oral malignancies are squamous cell carcinoma (SCC). Tobacco smoking is considered as the most important causative agent for SCC. Despite aggressive and multidisciplinary treatment approaches, there has been no significant improvement in 5-year survival over the past 20 years. Several prognostic and predictive clinical, pathological...

Application of DNA Molecular Markers in Plant Breeding (Review article)

Plant Breeding has utilized a wide range of techniques and methods to improve the quality and quantity of plants. The molecular markers are the tools that have provided a new perspective for plant breeding advancements. This article has reviewed the various advantages and uses of molecular markers and the utilization of the high potential of natural polymorphisms within communities, combined wi...

Prognostic value of simple inflammation based markers in hepatocellular carcinoma

Despite recent progression in cancer diagnosis and treatment, hepatocellular carcinoma (HCC) remains a destructive disease with a dismal prognosis. As a hallmark of cancer, tumor-associated systemic inflammation and tumor inflammatory microenvironment play significant roles in cancer development and progression. HCC represents a typical instance of inflammation-related cancer since most HCC cas...

New strategies in hepatocellular carcinoma: genomic prognostic markers.

Accurate prognosis prediction in oncology is critical. In patients with hepatocellular carcinoma (HCC), unlike most solid tumors, the coexistence of two life-threatening conditions, cancer and cirrhosis, makes prognostic assessments difficult. Despite the usefulness of clinical staging systems for HCC in routine clinical decision making (e.g., Barcelona-Clinic Liver Cancer algorithm), there is ...

Hepatocellular Carcinoma in Sheep